Amivantamab (Anti-HGFR / c-Met)
Amivantamab (Anti-HGFR / c-Met) is a human bispecific antibody targeting EGFR-MET.It has immune anticancer activity in non-small cell lung cancer (NSCLC). MW :146.1 KD.
Supplier | Selleck Chemicals |
---|---|
Product # | A2601 |
Sku # | A2601-1mg*25 |
Pricing | 1mg*25, $2970.00 |